These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 7955495)

  • 1. Juxta-articular fibrotic nodules in Borrelia infection--ultrastructural details of therapy-induced regression.
    Marsch WC; Wolter M; Mayet A
    Clin Exp Dermatol; 1994 Sep; 19(5):394-8. PubMed ID: 7955495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Juxta-articular fibroid nodules and acrodermatitis chronica atrophicans in late stage Lyme borreliosis].
    Kluge K; Krahl D; Kramer K; Yaguboglu R
    Hautarzt; 2000 May; 51(5):345-8. PubMed ID: 10875073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cutaneous fibroses induced by Borrelia burgdorferi.
    Marsch WC; Mayet A; Wolter M
    Br J Dermatol; 1993 Jun; 128(6):674-8. PubMed ID: 8338751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lyme disease: the evolution of erythema chronicum migrans into acrodermatitis chronica atrophicans.
    Patmas MA
    Cutis; 1993 Sep; 52(3):169-70. PubMed ID: 8243101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cutaneous manifestations of Lyme borreliosis.
    Aberer E; Klade H
    Infection; 1991; 19(4):284-6. PubMed ID: 1917047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular subtyping of Borrelia burgdorferi in erythema migrans and acrodermatitis chronica atrophicans.
    Wienecke R; Zöchling N; Neubert U; Schlüpen EM; Meurer M; Volkenandt M
    J Invest Dermatol; 1994 Jul; 103(1):19-22. PubMed ID: 8027576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation of Borrelia burgdorferi sensu lato from a fibrous nodule in a patient with acrodermatitis chronica atrophicans.
    Maraspin V; Ruzić-Sabljić E; Strle F
    Wien Klin Wochenschr; 2002 Jul; 114(13-14):533-4. PubMed ID: 12422596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphoproliferative responses to Borrelia burgdorferi in patients with erythema migrans, acrodermatitis chronica atrophicans, lymphadenosis benigna cutis, and morphea.
    Buechner SA; Lautenschlager S; Itin P; Bircher A; Erb P
    Arch Dermatol; 1995 Jun; 131(6):673-7. PubMed ID: 7778918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary cutaneous marginal zone lymphoma associated with juxta-articular fibrotic nodules in a teenager.
    Ghatalia P; Porter J; Wroblewski D; Carlson JA
    J Cutan Pathol; 2013 May; 40(5):477-84. PubMed ID: 23578183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Borrelia infections of the skin--progress of knowledge since the discovery of Lyme disease].
    Garbe C
    Hautarzt; 1991 Jun; 42(6):356-65. PubMed ID: 1917458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interstitial granulomatous dermatitis with histiocytic pseudorosettes: a new histopathologic pattern in cutaneous borreliosis. Detection of Borrelia burgdorferi DNA sequences by a highly sensitive PCR-ELISA.
    Moreno C; Kutzner H; Palmedo G; Goerttler E; Carrasco L; Requena L
    J Am Acad Dermatol; 2003 Mar; 48(3):376-84. PubMed ID: 12637917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymerase chain reaction control of antibiotic treatment in dermatoborreliosis.
    Muellegger R; Zoechling N; Schluepen EM; Soyer HP; Hoedl S; Kerl ; Volkenandt M
    Infection; 1996; 24(1):76-9. PubMed ID: 8852476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A two year prospective study to compare culture and polymerase chain reaction amplification for the detection and diagnosis of Lyme borreliosis.
    Picken MM; Picken RN; Han D; Cheng Y; Ruzic-Sabljic E; Cimperman J; Maraspin V; Lotric-Furlan S; Strle F
    Mol Pathol; 1997 Aug; 50(4):186-93. PubMed ID: 9350301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential expression of cytokine mRNA in skin specimens from patients with erythema migrans or acrodermatitis chronica atrophicans.
    Müllegger RR; McHugh G; Ruthazer R; Binder B; Kerl H; Steere AC
    J Invest Dermatol; 2000 Dec; 115(6):1115-23. PubMed ID: 11121150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contributions to the treatment of dermatologic manifestations of Lyme borreliosis.
    Hercogová J; Tománková M; Barták P
    Cutis; 1992 Jun; 49(6):409-11. PubMed ID: 1628507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in Borrelia burgdorferi-specific serum IgG antibody levels in patients treated for acrodermatitis chronica atrophicans.
    Olsson I; Asbrink E; von Stedingk M; von Stedingk LV
    Acta Derm Venereol; 1994 Nov; 74(6):424-8. PubMed ID: 7701871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lyme borreliosis.
    Scarpa C; Trevisan G; Stinco G
    Dermatol Clin; 1994 Oct; 12(4):669-85. PubMed ID: 7805296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. No evidence for Borrelia burgdorferi-specific DNA in lesions of localized scleroderma.
    Wienecke R; Schlüpen EM; Zöchling N; Neubert U; Meurer M; Volkenandt M
    J Invest Dermatol; 1995 Jan; 104(1):23-6. PubMed ID: 7798636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Borrelial erythema of the face].
    de Heller-Milev M; Peter O; Panizzon RG; Laffitte E
    Ann Dermatol Venereol; 2008 Dec; 135(12):852-4. PubMed ID: 19084697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term prognosis in patients treated for erythema chronicum migrans and acrodermatitis chronica atrophicans.
    Hulshof MM; Vandenbroucke JP; Nohlmans LM; Spanjaard L; Bavinck JN; Dijkmans BA
    Arch Dermatol; 1997 Jan; 133(1):33-7. PubMed ID: 9006370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.